Delivery Order SPE2DR25D3201-SPE2DR26FT4JV
Award Date 12/2/25
Potential Completion Date 12/23/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,499.84 to AmerisourceBergen Drug Corp for ProQuad vials on August 25, 2025, with completion targeted for September 16, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order part of the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.91 to AmerisourceBergen Drug Corp for ProQuad vials on October 29, 2025, with completion scheduled by November 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, supporting the federal government's immunization and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency awarded a delivery order valued at $26,281.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery...
- The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and...
- The Defense Logistics Agency awarded a delivery order valued at $7,693.53 to AmerisourceBergen Drug Corp for ProQuad vials on December 9, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, supporting the military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,745.76 to AmerisourceBergen Drug Corp for ProQuad vials on June 16, 2025, with an ultimate completion date of July 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, representing a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for ProQuad vials on August 15, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, representing...
- The Defense Logistics Agency awarded a delivery order valued at $24,814.95 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine indicated for prevention of measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for...